Patents by Inventor Eric M. Tam

Eric M. Tam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220281990
    Abstract: Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 8, 2022
    Inventors: Yu ZHOU, James D. MARKS, Marco MUDA, James Frank SAMPSON, Eric M. TAM, Ross Bane FULTON
  • Publication number: 20210371537
    Abstract: Anti-TNFR2 antibodies which bind to particular human TNFR2 epitopes, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer are disclosed.
    Type: Application
    Filed: September 18, 2019
    Publication date: December 2, 2021
    Inventors: Eric M. TAM, Marco MUDA, Klaus Andreas RAUE, Vinodh B. KURELLA, Daryl Clark DRUMMOND, Ross Bane FULTON, Fabien DEPIS, Anne-Sophie DUGAST, Jian TANG, Sandeep KUMAR
  • Publication number: 20190185541
    Abstract: Provided herein are methods of identifying cancer patients (e.g., colorectal cancer cancers) who will benefit from treatment with a TRAIL-based therapeutic or death receptor agonist based on their levels of DR4 and cIAP1. Also provided are methods of treating a patient diagnosed with cancer (e.g., colorectal cancer) based on their levels of DR4 and cIAP1.
    Type: Application
    Filed: June 13, 2017
    Publication date: June 20, 2019
    Inventors: Tamara DAKE, Sara GHASSEMIFAR, Yasmin HASHAMBHOY-RAMSAY, Diana Hung-yi Chai MARCANTONIO, Eric M. TAM, Haluk YUZUGULLU
  • Publication number: 20190077870
    Abstract: Engineered single chain trail molecules are provided, as are particular mutations and combinations of mutations that improve the stability and manufacturability of such molecules. These molecules are provided for use as anti-cancer therapeutics.
    Type: Application
    Filed: March 16, 2017
    Publication date: March 14, 2019
    Inventors: Diana Hung-yi Chai MARCANTONIO, Stephen L. SAZINSKY, Birgit M. SCHOEBERL, Eric M. TAM
  • Publication number: 20140038842
    Abstract: Novel materials and methods useful for displaying polypeptides on the surface of a cell are provided, including cell surface proteins fused to a PDZ domain peptide and antibodies fused to PDZ-binding peptides.
    Type: Application
    Filed: December 28, 2011
    Publication date: February 6, 2014
    Applicant: XOMA TECHNOLOGY
    Inventors: Eric M. Tam, Isaac J. Rondon, Chao B. Huang, Violet Votin